Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionCNB Bank
Latest Disclosed Ownership1,950 shares
Latest Disclosed Value $ 271,772
CNB Bank reports 6.61% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 6, 2026 - CNB Bank filed a 13F-HR form disclosing ownership of 1,950 shares of Gilead Sciences, Inc. (US:GILD) valued at $271,772 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 2,088 shares of Gilead Sciences, Inc.. This represents a change in shares of -6.61% during the quarter. The current value of the position is $251,531 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F GILEAD SCIENCES COM 375558103 1,950 -138 -6.61 272 5.86 0.1143
2026-02-11 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,088 58 2.86 256 13.78 0.1049
2025-10-30 2025-09-30 13F GILEAD SCIENCES COM 375558103 2,030 1,448 248.80 225 251.56 0.0939
2025-07-31 2025-06-30 13F GILEAD SCIENCES COM 375558103 582 0 0.00 65 -1.54 0.0306
2025-04-24 2025-03-31 13F GILEAD SCIENCES COM 375558103 582 0 0.00 65 22.64 0.0330
2025-01-15 2024-12-31 13F Gilead Sciences COM 375558103 582 0 0.00 54 10.42 0.0250
2024-10-18 2024-09-30 13F Gilead Sciences COM 375558103 582 3 0.52 49 23.08 0.0226
2024-08-08 2024-06-30 13F Gilead Sciences COM 375558103 579 0 0.00 40 -7.14 0.0191
2024-05-02 2024-03-31 13F Gilead Sciences COM 375558103 579 0 0.00 42 -8.70 0.0207
2024-01-31 2023-12-31 13F Gilead Sciences COM 375558103 579 0 0.00 47 6.98 0.0252
2023-11-02 2023-09-30 13F Gilead Sciences COM 375558103 579 579 43 0.0255
2023-08-08 2023-06-30 13F Gilead Sciences COM 375558103 0 -250 -100.00 0 -100.00
2023-05-10 2023-03-31 13F Gilead Sciences COM 375558103 250 0 0.00 21 -4.76 0.0126
2023-02-13 2022-12-31 13F Gilead Sciences COM 375558103 250 0 0.00 21 40.00 0.0134
2022-11-14 2022-09-30 13F Gilead Sciences COM 375558103 250 0 0.00 15 0.00 0.0101
2022-08-19 2022-06-30 13F/A-1 Gilead Sciences COM 375558103 250 -18 -6.72 15 -6.25 0.0097
2022-08-10 2022-06-30 13F Gilead Sciences COM 375558103 250 -18 15 0.0062
2022-04-13 2022-03-31 13F Gilead Sciences COM 375558103 268 -18 -6.29 16 -23.81 0.0089
2022-01-31 2021-12-31 13F Gilead Sciences COM 375558103 286 0 0.00 21 5.00 0.0115
2021-11-02 2021-09-30 13F Gilead Sciences COM 375558103 286 -59 -17.10 20 -16.67 0.0120
2021-07-29 2021-06-30 13F Gilead Sciences COM 375558103 345 27 8.49 24 14.29 0.0150
2021-05-03 2021-03-31 13F Gilead Sciences COM 375558103 318 0 0.00 21 10.53 0.0145
2021-01-27 2020-12-31 13F Gilead Sciences COM 375558103 318 36 12.77 19 5.56 0.0143
2020-10-26 2020-09-30 13F Gilead Sciences COM 375558103 282 0 0.00 18 -18.18 0.0152
2020-07-14 2020-06-30 13F Gilead Sciences COM 375558103 282 0 0.00 22 4.76 0.0194
2020-05-13 2020-03-31 13F Gilead Sciences COM 375558103 282 250 781.25 21 950.00 0.0226
2020-01-27 2019-12-31 13F Gilead Sciences COM 375558103 32 0 0.00 2 0.00 0.0017
2019-11-04 2019-09-30 13F Gilead Sciences COM 375558103 32 -108 -77.14 2 -77.78 0.0019
2019-08-14 2019-06-30 13F Gilead Sciences COM 375558103 140 108 337.50 9 350.00 0.0077
2019-04-29 2019-03-31 13F Gilead Sciences COM 375558103 32 0 0.00 2 0.00 0.0010
2019-02-06 2018-12-31 13F Gilead Sciences COM 375558103 32 0 0.00 2 0.00 0.0013
2018-11-13 2018-09-30 13F Gilead Sciences COM 375558103 32 0 0.00 2 0.00 0.0011
2018-08-14 2018-06-30 13F Gilead Sciences COM 375558103 32 32 2 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.